Connect with us

COVID-19

Federal Court rules Biden administration likely violated First Amendment forcing censorship of COVID-19, election on social media platforms

Published

on

googleimage

The Fifth Circuit U.S. Court of Appeals ruled that the Biden administration “likely violated the First Amendment” in its censorship of the COVID-19 narrative among social media platforms. 

The violation of the First Amendment comes from pressuring social-media platforms to censor posts about Covid-19 and elections.

The ruling states that the White House likely “coerced the platforms to make their moderation decisions by way of intimidating messages and threats of adverse consequences.”

The panel consisted of three judges found that the administration “significantly encouraged the platforms’ decisions by commandeering their decision-making processes, both in violation of the First Amendment.”

The federal court’s decision comes in response to the lawsuit filed by the attorneys general of Louisiana and Missouri last year. Missouri attorney general Andrew Bailey celebrated the decision in a post on X, saying it would prevent federal officials “from violating the First Amendment rights of millions of Americans.”

National Review reports:

While the Biden White House and CDC allegedly pressured Facebook and YouTube to adopt specific policies around Covid-19 and vaccination-related information, the judges noted the FBI regularly met with tech companies ahead of the 2020 elections. The agency’s activities were “not limited to purely foreign threats,” as the FBI flagged posts that originated inside the U.S. as well, including those that contained incorrect poll hours or mail-in voting procedures.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

New data reveals NIH scientists collected $710 Million in royalties during pandemic

Published

on

GettyImages 1237662885 scaled

New data from the National Institutes of Health (NIH) reveal that the agency and its scientists collected $710 million in royalties from late 2021 through 2023. These payments, made by private companies such as pharmaceutical firms, are for licensing medical innovations developed by government scientists. A significant portion of these funds — $690 million — was directed to the National Institute of Allergy and Infectious Diseases (NIAID), led by Dr. Anthony Fauci, and its 260 scientists.

An in depth report by the New York Post reveals that the vast majority of the royalties collected during the pandemic era went to NIAID, the subagency under Dr. Fauci. The NIH has been secretive about disclosing details of this private royalty complex. OpenTheBooks.com, an organization advocating for government transparency, had to sue to uncover royalties paid from September 2009 to October 2021, which amounted to $325 million over 56,000 transactions. A second lawsuit, with Judicial Watch as counsel, was necessary to release the latest data.

During the pandemic, royalty payments to the NIH more than doubled compared to the previous twelve years combined, amounting to $1.036 billion. However, it remains unclear if royalties from COVID-19 vaccines, particularly from Pfizer and Moderna (the latter having agreed to pay $400 million to NIH), are included in these figures. The NIH has not provided clarity on this matter.

Dr. Anthony Fauci, a key figure in the U.S. COVID-19 response, is set to testify before the House Select Subcommittee on the Coronavirus Pandemic to address potential conflicts of interest and transparency issues that have plagued NIH’s handling of royalties and FOIA requests.

Fauci’s deputy, Dr. David Morens, has been implicated in using strategies to circumvent the federal Freedom of Information Act (FOIA), such as misspelling words and using physical couriers for messages. These actions have drawn significant criticism and calls for greater transparency.

Senator Rand Paul (R-Ky.) has sponsored the Royalty Transparency Act, which has unanimously passed the committee stage and is awaiting a floor vote. This act aims to provide greater transparency regarding royalty payments to government scientists.

 

Continue Reading

Trending